PMAM
RMD icon

Picton Mahoney Asset Management’s ResMed RMD Stock Holding History

Picton Mahoney Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,451
Closed -$632K – 1186
2025
Q2 		$632K Buy
+2,451
New +$585K 0.01% 453
2023
Q2 		– Sell
-8,760
Closed -$1.92M – 478
2023
Q1 		$1.92M Sell
8,760
-1,120
-11% -$243K 0.09% 244
2022
Q4 		$2.06M Buy
+9,880
New +$2.17M 0.1% 263

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Picton Mahoney Asset Management's RMD Position: Q3 2025 in Review

Picton Mahoney Asset Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 2,451 shares — an estimated $632K sold.

Picton Mahoney Asset Management first reported a position in RMD in Q4 2022 and held it in 3 quarters. The position peaked at $2.06M in Q4 2022. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Picton Mahoney Asset Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 2,451 ResMed shares in Q3 2025, an estimated $632K.
  • Picton Mahoney Asset Management first reported a position in ResMed in Q4 2022 and held it in 3 quarters.
  • Picton Mahoney Asset Management's ResMed position peaked at $2.06M in Q4 2022.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.